Nasdaq

Masimo (MASI) Reports SedLine's Psi & DSA Parameter Findings

Masimo Corporation MASI recently announced the findings of a prospective study published in Frontiers in Neurology. The study evaluated whether general anesthesia guided by Masimo SedLine Brain ...
Nasdaq

Masimo (MASI) Receives FDA Approval for SedLine, Shares Up

In a recent breakthrough, Masimo CorporationMASI announced that its Next Generation SedLine brain function monitoring has received clearance from the FDA. The device will provide clinicians real-time ...
Business Wire

Masimo Announces FDA Clearance of Next Generation SedLine ® Brain Function Monitoring

IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) announced today FDA clearance of Next Generation SedLine ® brain function monitoring. SedLine helps clinicians monitor the state of the brain ...
Business Wire

Masimo Announces CE Marking of Pediatric Indication for Next Generation SedLine ® Brain Function Monitoring

NEUCHATEL, Switzerland--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) announced today the CE marking of Next Generation SedLine ® brain function monitoring for pediatric patients (1-18 years of age). With ...
Pharmabiz

Study finds Masimo’s SedLine brain function monitoring shows advantages during pediatric anesthesia

Masimo, a global medical technology company developing and producing a wide array of industry-leading monitoring technologies, including innovative measurements, sensors, patient monitors, and ...